437 related articles for article (PubMed ID: 22448610)
1. Prevalence, symptoms and management of uterine fibroids: an international internet-based survey of 21,746 women.
Zimmermann A; Bernuit D; Gerlinger C; Schaefers M; Geppert K
BMC Womens Health; 2012 Mar; 12():6. PubMed ID: 22448610
[TBL] [Abstract][Full Text] [Related]
2. The management of uterine leiomyomas.
Vilos GA; Allaire C; Laberge PY; Leyland N;
J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
[TBL] [Abstract][Full Text] [Related]
3. Patient-reported prevalence and symptomatic burden of uterine fibroids among women in the United States: findings from a cross-sectional survey analysis.
Fuldeore MJ; Soliman AM
Int J Womens Health; 2017; 9():403-411. PubMed ID: 28652819
[TBL] [Abstract][Full Text] [Related]
4. Uterine fibroids and gynecologic pain symptoms in a population-based study.
Lippman SA; Warner M; Samuels S; Olive D; Vercellini P; Eskenazi B
Fertil Steril; 2003 Dec; 80(6):1488-94. PubMed ID: 14667888
[TBL] [Abstract][Full Text] [Related]
5. Predictors of hysterectomy as a treatment for menstrual symptoms.
Graham M; James EL; Keleher H
Womens Health Issues; 2008; 18(4):319-27. PubMed ID: 18590884
[TBL] [Abstract][Full Text] [Related]
6. Use of medical, surgical and complementary treatments among women with fibroids.
Jacoby VL; Jacoby A; Learman LA; Schembri M; Gregorich SE; Jackson R; Kuppermann M
Eur J Obstet Gynecol Reprod Biol; 2014 Nov; 182():220-5. PubMed ID: 25445104
[TBL] [Abstract][Full Text] [Related]
7. Optimizing research in symptomatic uterine fibroids with development of a computable phenotype for use with electronic health records.
Hoffman SR; Vines AI; Halladay JR; Pfaff E; Schiff L; Westreich D; Sundaresan A; Johnson LS; Nicholson WK
Am J Obstet Gynecol; 2018 Jun; 218(6):610.e1-610.e7. PubMed ID: 29432754
[TBL] [Abstract][Full Text] [Related]
8. Utility values for pre-menopausal women suffering from symptomatic uterine fibroids.
Hux M; Ng C; Ortega GL; Ferrazzi S; Goeree R
Expert Rev Pharmacoecon Outcomes Res; 2015 Feb; 15(1):181-9. PubMed ID: 25284595
[TBL] [Abstract][Full Text] [Related]
9. Uterine fibroids: Correlations of anemia and pain to fibroid location and uterine weight.
Bachmann GA; Bahouth LA; Amalraj P; Mhamunkar V; Hoes K; Ananth CV
J Reprod Med; 2011; 56(11-12):463-6. PubMed ID: 22195327
[TBL] [Abstract][Full Text] [Related]
10. Examining the relationship between uterine fibroids and dyspareunia among premenopausal women in the United States.
Moshesh M; Olshan AF; Saldana T; Baird D
J Sex Med; 2014 Mar; 11(3):800-8. PubMed ID: 24467730
[TBL] [Abstract][Full Text] [Related]
11. Burden, Prevalence, and Treatment of Uterine Fibroids: A Survey of U.S. Women.
Marsh EE; Al-Hendy A; Kappus D; Galitsky A; Stewart EA; Kerolous M
J Womens Health (Larchmt); 2018 Nov; 27(11):1359-1367. PubMed ID: 30230950
[TBL] [Abstract][Full Text] [Related]
12. Predictors of response for elagolix with add-back therapy in women with heavy menstrual bleeding associated with uterine fibroids.
Al-Hendy A; Bradley L; Owens CD; Wang H; Barnhart KT; Feinberg E; Schlaff WD; Puscheck EE; Wang A; Gillispie V; Hurtado S; Muneyyirci-Delale O; Archer DF; Carr BR; Simon JA; Stewart EA
Am J Obstet Gynecol; 2021 Jan; 224(1):72.e1-72.e50. PubMed ID: 32702363
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of the selective progesterone receptor modulator asoprisnil for heavy menstrual bleeding with uterine fibroids: pooled analysis of two 12-month, placebo-controlled, randomized trials.
Stewart EA; Diamond MP; Williams ARW; Carr BR; Myers ER; Feldman RA; Elger W; Mattia-Goldberg C; Schwefel BM; Chwalisz K
Hum Reprod; 2019 Apr; 34(4):623-634. PubMed ID: 30865281
[TBL] [Abstract][Full Text] [Related]
14. The fibroid growth study: determinants of therapeutic intervention.
Davis BJ; Haneke KE; Miner K; Kowalik A; Barrett JC; Peddada S; Baird DD
J Womens Health (Larchmt); 2009 May; 18(5):725-32. PubMed ID: 19366341
[TBL] [Abstract][Full Text] [Related]
15. Selective progesterone receptor modulators (SPRMs) for uterine fibroids.
Murji A; Whitaker L; Chow TL; Sobel ML
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD010770. PubMed ID: 28444736
[TBL] [Abstract][Full Text] [Related]
16. Individualized vaginal bleeding experience of women with uterine fibroids in the PEARL I randomized controlled trial comparing the effects of ulipristal acetate or placebo.
Barlow DH; Lumsden MA; Fauser BC; Terrill P; Bestel E
Hum Reprod; 2014 Mar; 29(3):480-9. PubMed ID: 24457604
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology and management of uterine fibroids.
Giuliani E; As-Sanie S; Marsh EE
Int J Gynaecol Obstet; 2020 Apr; 149(1):3-9. PubMed ID: 31960950
[TBL] [Abstract][Full Text] [Related]
18. [Prevalence of uterine fibroids in France and impact on quality of life: results of a survey among 2500 women between 30-55 years].
Fernandez H; Chabbert Buffet N; Allouche S
J Gynecol Obstet Biol Reprod (Paris); 2014 Nov; 43(9):721-7. PubMed ID: 25124196
[TBL] [Abstract][Full Text] [Related]
19. A Population-Based Study of the Prevalence of Abnormal Uterine Bleeding and its Related Factors among Iranian Reproductive-Age Women: An Updated Data.
Kazemijaliseh H; Ramezani Tehrani F; Behboudi-Gandevani S; Khalili D; Hosseinpanah F; Azizi F
Arch Iran Med; 2017 Sep; 20(9):558-563. PubMed ID: 29048917
[TBL] [Abstract][Full Text] [Related]
20. Clinical presentation of fibroids.
Gupta S; Jose J; Manyonda I
Best Pract Res Clin Obstet Gynaecol; 2008 Aug; 22(4):615-26. PubMed ID: 18372219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
